Your browser doesn't support javascript.
loading
A rare case of misoprostol hypersensitivity.
Das, Rituparna; Panda, Subrat; Sharma, Nalini; Deb, Prakash.
Afiliación
  • Das R; Department of Obstetrics and Gynaecology, Critical Care and Pain, NEIGRIHMS, Shillong, Meghalaya, India.
  • Panda S; Department of Obstetrics and Gynaecology, Critical Care and Pain, NEIGRIHMS, Shillong, Meghalaya, India.
  • Sharma N; Department of Obstetrics and Gynaecology, Critical Care and Pain, NEIGRIHMS, Shillong, Meghalaya, India.
  • Deb P; Department of Anaesthesia, Critical Care and Pain, NEIGRIHMS, Shillong, Meghalaya, India.
J Family Med Prim Care ; 11(5): 2226-2227, 2022 May.
Article en En | MEDLINE | ID: mdl-35800489
Medical abortion using mifepristone-misoprostol regimen has been considered to be a safe and effective method for pregnancy termination. Misoprostol is a frequently used well tolerated drug with mild and transient side effects. Considering the safety profile mifepristone-misoprostol regimen has also been advocated by many for home-based medical abortion. However, we report herein a rare case of hypersensitivity reaction to sublingual misoprostol administered for first trimester medical abortion, where timely diagnosis and prompt intervention prevented life-threatening airway obstruction. The possibility of such rare event should be kept in mind and included in patient counselling and information especially for those who opt for outpatient abortion care so that they can seek medical help at the earliest.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: J Family Med Prim Care Año: 2022 Tipo del documento: Article País de afiliación: India Pais de publicación: India

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: J Family Med Prim Care Año: 2022 Tipo del documento: Article País de afiliación: India Pais de publicación: India